BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1014 related articles for article (PubMed ID: 17265452)

  • 1. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
    Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
    J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
    Petroianu GA; Arafat K; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
    Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
    J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Shafiullah M; Kassa J; Kuca K
    J Appl Toxicol; 2007; 27(5):453-7. PubMed ID: 17304644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure?
    Lorke DE; Petroianu GA
    J Appl Toxicol; 2009 Aug; 29(6):459-69. PubMed ID: 19603416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication.
    Arshad M; Fatmi MQ; Musilek K; Hussain A; Kuca K; Petroianu G; Kalasz H; Nurulain SM
    Toxicol Mech Methods; 2018 Jan; 28(1):62-68. PubMed ID: 28722512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
    Jeong HC; Park NJ; Chae CH; Musilek K; Kassa J; Kuca K; Jung YS
    Bioorg Med Chem; 2009 Sep; 17(17):6213-7. PubMed ID: 19665386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
    Hasan MY; Nurulain SM; Arafat K; Naseer OP; Petroianu GA
    J Appl Toxicol; 2004; 24(4):257-60. PubMed ID: 15300712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Arafat K; Rajan S; Hasan MY
    Arch Toxicol; 2006 Nov; 80(11):777-84. PubMed ID: 16598495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
    Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
    Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
    Musilova L; Kuca K; Jung YS; Jun D
    Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
    Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
    J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.
    Lorke DE; Hasan MY; Nurulain SM; Kuca K; Schmitt A; Petroianu GA
    Toxicol Mech Methods; 2009 May; 19(4):327-33. PubMed ID: 19778224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
    Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice.
    dos Santos AA; dos Santos DB; Ribeiro RP; Colle D; Peres KC; Hermes J; Barbosa AM; Dafré AL; de Bem AF; Kuca K; Farina M
    Neurotoxicology; 2011 Dec; 32(6):888-95. PubMed ID: 21723318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon.
    Thiermann H; Eyer P; Worek F; Szinicz L
    Toxicology; 2005 Oct; 214(3):190-7. PubMed ID: 16040183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon.
    Petroianu G; Kühn F; Thyes C; Ewald V; Missler A
    J Appl Toxicol; 2003; 23(1):75-9. PubMed ID: 12518340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New oxime reactivators connected with CH2O(CH2)nOCH2 linker and their reactivation potency for organophosphorus agents-inhibited acetylcholinesterase.
    Yang GY; Oh KA; Park NJ; Jung YS
    Bioorg Med Chem; 2007 Dec; 15(24):7704-10. PubMed ID: 17869525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine.
    Petroianu GA; Arafat K; Schmitt A; Hasan MY
    J Appl Toxicol; 2005; 25(1):60-7. PubMed ID: 15669026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.